GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma.

Wang G, Liu Z, Zhou T, Yang B, Chen J, Chen J, Huang K, Xu Y, Tang Q, Yin X, Xiao G, Zhang S

Open source

DOI
10.32604/or.2026.083840
Published
2026
Container
Oncology research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.32604/or.2026.083840,
  title = {GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma.},
  author = {Wang G and Liu Z and Zhou T and Yang B and Chen J and Chen J and Huang K and Xu Y and Tang Q and Yin X and Xiao G and Zhang S},
  year = {2026},
  journal = {Oncology research},
  doi = {10.32604/or.2026.083840},
  url = {https://doi.org/10.32604/or.2026.083840}
}

RIS

TY  - JOUR
TI  - GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma.
AU  - Wang G
AU  - Liu Z
AU  - Zhou T
AU  - Yang B
AU  - Chen J
AU  - Chen J
AU  - Huang K
AU  - Xu Y
AU  - Tang Q
AU  - Yin X
AU  - Xiao G
AU  - Zhang S
PY  - 2026
JO  - Oncology research
DO  - 10.32604/or.2026.083840
UR  - https://doi.org/10.32604/or.2026.083840
ER  - 

APA

G, W., Z, L., T, Z., B, Y., J, C., J, C., K, H., Y, X., Q, T., X, Y., G, X., & S, Z. (2026). GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma.. Oncology research. https://doi.org/10.32604/or.2026.083840

Source records